The test is designed for people aged 45 years and above who are at average colorectal cancer risk. Credit: aslysun / Shutterstock.com. · Medical Device Network · aslysun / Shutterstock.com. The US ...
ST. LOUIS, July 24, 2025--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, received FDA approval to ...
BIOHIT OYJ is excited to announce the launch of the BIOHIT FAEX Sample System, a stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic workflow.
BIOHIT Oyj is excited to announce the launch of the BIOHIT FAEX Sample System, a revolutionary stool sample collection and handling solution that can be seamlessly incorporated into any diagnostic ...